Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01282437 : Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC
PhasePhase 3
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- UICC stage IIIA or IIIB (without malignant pleural of pericardial effusion) non-small
cell lung cancer (histology or cytology)

- Whole body FDG-PET-scan before start of therapy available: No distant metastases

- CT or MRI of the brain before the start of radical therapy available: No brain

- Platinum-based chemotherapy is mandatory

- Radical local therapy: concurrent of sequential chemotherapy (platinum-based) and
radiotherapy with or without surgery

- Radiotherapy dose without surgery at least a biological equivalent of 60Gy

- No prior cranial irradiation

- Patients must sign a study-specific informed consent at the time of registration

Exclusion Criteria:

- The opposite of the above
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557